One Year On, FDA Generic Drug Cluster Focuses On Facilitating Collaboration
Group Has Made Significant Progress Regarding Data Sharing
Following its inaugural year, the FDA’s Generic Drug Cluster has formed data sharing arrangements concerning a number of vital indications.
